News headlines about HCA Healthcare (NYSE:HCA) have been trending somewhat positive on Tuesday, Accern Sentiment reports. The research group rates the sentiment of media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. HCA Healthcare earned a daily sentiment score of 0.11 on Accern’s scale. Accern also gave news stories about the company an impact score of 45.9237770208736 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Here are some of the media headlines that may have effected Accern’s analysis:
- Ravi Chari Appointed President of HCA’s West Florida Division (finance.yahoo.com)
- Booming Nashville tech company raises $30 million from big-name investors (finance.yahoo.com)
- HCA appoints new president for West Florida Division (finance.yahoo.com)
- HCA Healthcare (HCA) Cut to “Hold” at Zacks Investment Research (americanbankingnews.com)
- Entrepreneur Center unveils new accelerator for health care startups – Nashville Business Journal (bizjournals.com)
A number of research analysts recently issued reports on the company. Zacks Investment Research lowered HCA Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday. Piper Jaffray Companies reaffirmed a “hold” rating and set a $101.00 target price on shares of HCA Healthcare in a report on Tuesday, January 30th. BMO Capital Markets lifted their target price on HCA Healthcare from $96.00 to $115.00 and gave the stock an “outperform” rating in a report on Thursday, February 1st. They noted that the move was a valuation call. Sanford C. Bernstein reaffirmed a “market perform” rating and set a $116.00 target price (up from $105.00) on shares of HCA Healthcare in a report on Thursday, February 1st. Finally, SunTrust Banks set a $105.00 target price on HCA Healthcare and gave the stock a “buy” rating in a report on Thursday, December 21st. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and seventeen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $104.50.
Shares of HCA Healthcare (NYSE HCA) traded down $2.06 during midday trading on Tuesday, reaching $100.60. The company’s stock had a trading volume of 1,476,991 shares, compared to its average volume of 2,182,259. HCA Healthcare has a 12-month low of $71.18 and a 12-month high of $106.84. The firm has a market cap of $35,959.61, a price-to-earnings ratio of 16.94, a PEG ratio of 1.03 and a beta of 0.49. The company has a debt-to-equity ratio of -6.58, a current ratio of 1.62 and a quick ratio of 1.36.
HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 30th. The company reported $2.12 EPS for the quarter, topping the Zacks’ consensus estimate of $1.87 by $0.25. HCA Healthcare had a negative return on equity of 49.49% and a net margin of 4.89%. The firm had revenue of $11.56 billion during the quarter, compared to analyst estimates of $11.19 billion. During the same period last year, the company posted $1.80 EPS. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. equities research analysts forecast that HCA Healthcare will post 8.71 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 30th. Shareholders of record on Thursday, March 1st will be given a dividend of $0.35 per share. The ex-dividend date of this dividend is Wednesday, February 28th. This represents a $1.40 dividend on an annualized basis and a yield of 1.39%. HCA Healthcare’s payout ratio is presently 23.57%.
In other HCA Healthcare news, insider Charles J. Hall sold 35,949 shares of the firm’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $103.09, for a total transaction of $3,705,982.41. Following the completion of the sale, the insider now directly owns 111,237 shares in the company, valued at approximately $11,467,422.33. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Sandra L. Morgan sold 3,698 shares of the firm’s stock in a transaction dated Tuesday, February 6th. The stock was sold at an average price of $96.91, for a total value of $358,373.18. Following the sale, the senior vice president now owns 5,410 shares of the company’s stock, valued at $524,283.10. The disclosure for this sale can be found here. Insiders have sold a total of 479,918 shares of company stock valued at $48,186,093 over the last 90 days. Corporate insiders own 2.90% of the company’s stock.
HCA Healthcare Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.